The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen
Abstract
OBJECTIVE: To study the predictors of virological rebound in patients having early virological response to protease inhibitor (PI)-containing regimen. DESIGN AND METHODS: APROCO cohort study prospectively enrolled 1283 HIV-infected patients starting a PI-containing regimen in 1997-1999. Adherence to therapy was measured with self-administered questionnaires after 4 months of therapy (M4). Virological rebound was defined as a viral load (VL) > 500 copies/ml in patients having early virological response, defined as a VL < 500 copies/ml at M4. Predictors of time to virological rebound were studied with multivariate proportional hazards model. RESULTS: During a median follow-up of 20 months, virological rebound was observed in 32% of the 830 patients with early virological response. Virological rebound was more frequent when patients had received previous antiretroviral treatment [adjusted hazards ratio (HR) = 2.4; P < 0.0001], were younger (HR = 1.4 per each 10 years younger; P < 0.0001), had baseline CD4 cell count < 500 x 106/l (HR = 2.3; P < 0.001), had higher baseline VL (HR = 1.4 per each log10 copies/ml higher; P < 0.001), reported low adherence to therapy at M4 (HR = 2.1; P < 0.001) or had stopped PI at M4 (HR = 1.7; P = 0.04). CONCLUSION: Initiation of treatment at a stage of preserved immunity is associated with a more durable virological response under protease inhibitor. Every effort should be made to monitor and strengthen adherence to therapy, even in patients having early virological response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bardsley-Elliot (2000) · doi:10.2165/00003495-200059030-00014 · Cited by 127
Cited by
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006) · AIDS and Behavior · doi:10.1007/s10461-006-9078-6 · Cited by 653
Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy
Sanders, G. D., Bayoumi, A. M., Sundaram, V., Bilir, S. P., Neukermans, C. P., Rydzak, C. E., Douglass, L. R., Lazzeroni, L. C., Holodniy, M., & Owens, D. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa042657 · Cited by 603
for the Canadian Observation Cohort (CANOC) Collaboration, Tanner, Z., Lachowsky, N., Ding, E., Samji, H., Hull, M., Cescon, A., Patterson, S., Chia, J., Leslie, A., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1926-z · Cited by 270
Metadata
- Authors
- Le Moing, V., Chêne, G., Carrieri, M. P., Alioum, A., Brun-Vézinet, F., Piroth, L., Cassuto, J. P., Moatti, J.-P., Raffi, F., & Leport, C.
- Venue
- AIDS
- Published
- 2002-01
- Volume
- 16
- Issue
- 1
- Pages
- 21-29
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2018551422
- Cited by
- 166
- References
- 1
- FWCI
- 14.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen. https://app.cochat.ai/papers/10.1097/00002030-200201040-00004
- The paper
- Le Moing, V., Chêne, G., Carrieri, M. P., Alioum, A., Brun-Vézinet, F., Piroth, L., Cassuto, J. P., Moatti, J.-P., Raffi, F., & Leport, C. (2002). Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen. AIDS. https://doi.org/10.1097/00002030-200201040-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.